Table 4.
Group 1 | Group 2 | P value† | |
---|---|---|---|
N. of participants | 154 | 59 | |
Choroidal hyperpermeability | 23.4 % | 6.8 % | 0.005 |
Punctate hyperfluorescence spot | |||
0–2 | 23.4 % | 28.8 % | 0.647 |
3–10 | 20.8 % | 23.7 % | |
10–20 | 27.3 % | 18.6 % | |
20–40 | 19.5 % | 16.9 % | |
>40 | 9.1 % | 11.9 % | |
Late geographic hyperfluorescence | 9.7 % | 1.7 % | 0.076 |
Spatially correlated punctate hyperfluorescence spots and DLD | 18.2 % | 0.0 % | <0.001 |
Spatially correlated punctate hyperfluorescence spots and choroidal hyperpermeability | 8.4 % | 5.1 % | 0.565 |
Group 1: fellow eye of unilateral polypoidal choroidal vasculopathy; Group 2: fellow eye of unilateral typical exudative
age-related macular degeneration; Group 3: fellow eye of unilateral epiretinal membrane, as a control
DLD, drusen-like deposits
† comparison of Groups 1 and 2